Acute Myeloblastic Leukemia
Acute Myeloblastic Leukemia (AML) is a fast-growing cancer of the blood and bone marrow that affects the production of blood cells, leading to symptoms such as fatigue, frequent infections, and easy bruising or bleeding.
Acute Myeloblastic Leukemia: Daratumumab with Chemotherapy
We are testing a new treatment combining daratumumab with chemotherapy for patients aged 60 and older with adverse risk acute myeloblastic leukemia. The goal is to see if this combination is safe and effective.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire D Angers
Service d'hématologie clinique
Ivry-sur-Seine, France
Centre Hospitalier Universitaire De Nantes
service d'hématologie clinique
Nantes, France
Centre Hospitalier Universitaire De Rennes
Service d'hématologie clinique
Rennes, France
Sponsor: Centre Hospitalier Universitaire De Nantes
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.